GGrantIndex
Sort

51,593 grants matching hepatitis

HEPATIC GENE TRANSFER FOR TREATMENT OF HEMOPHILIAS A &B

$439,648
Stanford University · R01 · FY2002 · HL

Metabolic Mechanisms of Naphthalene Toxicity in Lung

$439,585
Xinxin Ding · University Of Arizona · R01 · FY2021 · ES

Molecular and Cell Biology

$439,553
Joseph R Landolph · University Of Southern California · P30 · FY2010 · CA

Harnessing the power of peer navigation and mHealth to reduce health disparities in Appalachia

$439,496
Scott D Rhodes · Wake Forest University Health Sciences · R01 · FY2024 · NR

Vaccine against HCV in nonhuman primates

$439,478
Francois J Villinger · Stanford University · U19 · FY2022 · AI

Histone methylase MLL2 in regulation of SR-BI expression and plasma cholesterol

$439,360
Subhrangsu S Mandal · University Of Texas Arlington · R15 · FY2018 · HL

Determining how macrophages regulate immunity to Zika virus infection at the maternal-fetal interface

$439,360
Mehul Shamal Suthar · Emory University · U01 · FY2021 · AI

Biological Studies with Peroxisome Proliferators

$439,351
Northwestern University · R01 · FY2004 · GM

A Transporter-Based Predictive ADME Platform

$439,346
Mark S. Warren · Optivia Biotechnology, Inc. · R43 · FY2010 · RR

HDL metabolism: Influence of extracellular lipases

$439,329
Daniel James Rader · University Of Pennsylvania · R37 · FY2017 · HL

Developmental exposure to Bisphenol A and susceptibility to liver injury

$439,285
Angela L Slitt · University Of Rhode Island · R15 · FY2015 · ES

A Brain-Wide Neural Network for Glucosensory-Motor Integration During Hypoglycemia

$439,274
Alan G Watts · University Of Southern California · R01 · FY2019 · DK

Cytapheresis Of Volunteer Donors (MRI 2003-054)

$439,259
Josephine Egan · National Institute On Aging · ZID · FY2012 · AG

In Vitro Antiviral Screening Program

$439,191
Brent E Korba · Georgetown University · N01 · FY2010 · AI

Structure meets function for OATP1B1, a transporter involved in the uptake of endogenous and xenobiotic materials and drugs

$439,154
Aviv Paz · Hauptman-Woodward Medical Research Inst · R01 · FY2024 · GM

MECHANISMS AND STRATEGIES FOR INSULIN RESISTANCE IN AIDS

$439,132
Massachusetts General Hospital · R01 · FY2001 · DK

Characterizing the VZV-induced inflammatory response in temporal arteries from patients with giant cell arteritis

$439,097
Maria Acena Nagel · University Of Colorado Denver · P01 · FY2021 · AG

ADK Regulation of Fat Metabolism and Insulin Sensitivity

$439,088
Chaodong Wu · Texas A&M Agrilife Research · R01 · FY2023 · DK

Spectrum of Neuro-Cognitive Impairment in Cirrhosis

$439,035
Jasmohan S Bajaj · Virginia Commonwealth University · R01 · FY2011 · DK

Interaction between RNA interference and RNA editing pathways

$438,942
Kazuko Nishikura · Wistar Institute · R01 · FY2010 · GM

PROSPECTIVE LONGITUDINAL STUDY OF IWITH SCREEN FAILURES SECONDARY TO HISTOPATHOLOGY

$438,908
Sandy Feng · University Of California, San Francisco · R01 · FY2018 · DK

HIV and HIV/HCV-Infection, Disease Progression, Oxidative Stress and Antioxidants

$438,830
Marianna K Baum · Florida International University · R01 · FY2007 · DA

Antiviral actions of interferons

$438,818
Ganes C. Sen · Cleveland Clinic Lerner Com-Cwru · R01 · FY2011 · CA

Role of Human Apolipoprotein E in Hepatitis B Virus Infection andMorphogenesis

$438,751
Guangxiang George Luo · Wake Forest University Health Sciences · R01 · FY2024 · AI

HLA restriction and TCR affinity in HIV

$438,750
Daniel Garrett Kavanagh · Massachusetts General Hospital · R56 · FY2011 · AI